Thoughts on some of the latest health research stories in the media

I hope you have had a good Easter weekend. There have been three health research stories in the last week that have caught my attention.  Each story is significant in its own right.  But they also share a common theme around the importance of public participation in research. First up is the research published by King's College... Continue Reading →

PLoS ONE study – I’d go further: poor quality information undermines rights of clinical trial participants

On my recent visit to Newcastle, my afternoon was spent talking to, and answering questions from, the public about research.  Clinical trials featured heavily.  The most common theme was their frustration over the poor quality information given to trial participants before, during and after a trial had finished. The journal, PloS ONE, has today published a... Continue Reading →

UKCMRI Task Gets Bigger

So the UKCMRI partners were in front of the House of Commons Science and Technology Committee yesterday as were representatives of the local community.  Meanwhile the Science Minister, David Willetts, announced that the Government had agreed the business plan for the new centre as put forward by the Medical Research Council (MRC).   A good day all... Continue Reading →

More on Pfizer

Ther's a couple of good pieces in the FT (link will take you to the front page) about the Pfizer announcement yesterday. Actually, it's quite interesting reading the comments of Pfizer's CEO as reported this morning.  They give some insight into the self-critical eye that pharma is taking on how it has done things in the... Continue Reading →

Blog at WordPress.com.

Up ↑

%d bloggers like this: